Literature DB >> 31491787

Lack of HIV-1 integrase inhibitor resistance among 392 antiretroviral-naïve individuals in a tertiary care hospital in Beijing, China.

Lifeng Liu1,2,3, Lili Dai1,3, Jun Yao4, Pinliang Pan4, Li Li1,2, Zhiying Liu1,2, Xizhao An1,2, Lijun Sun1, Hao Wu1,2, Bin Su1,2, Tong Zhang1,2.   

Abstract

: Reports of resistance to integrase strand transfer inhibitors (INSTIs) are now not uncommon. We analyzed the HIV int gene from plasma of antiretroviral-naïve individuals during acute and chronic HIV-1 infection. No individual with major INSTI mutations was identified. Two individuals harbored INSTI accessory mutations E157Q/T97A were detected for the first time. Our results emphasize the need to consider testing for INSTI resistance at baseline as this class of drugs is increasingly used in clinical routine.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31491787     DOI: 10.1097/QAD.0000000000002282

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  3 in total

1.  Low Frequency of Integrase Inhibitor Resistance Mutations Among Therapy-Naïve HIV Patients in Southeast China.

Authors:  Jinglan Lai; Yuming Liu; Xiao Han; Aiqiong Huang; Jin Lin; Wen Ao; Hanhui Ye; Yahong Chen
Journal:  Drug Des Devel Ther       Date:  2021-02-26       Impact factor: 4.162

2.  Absence of Integrase Inhibitor-Associated Resistance Among Antiretroviral Therapy-Naïve HIV-1-Infected Adults in Guangdong Province, China, in 2018.

Authors:  Yun Lan; Linghua Li; Weilie Chen; Xizi Deng; Junbin Li; Qinghong Fan; Xiaoli Cai; Weiping Cai; Fengyu Hu
Journal:  Infect Drug Resist       Date:  2020-12-08       Impact factor: 4.003

3.  Drug Resistance to HIV-1 Integrase Inhibitors Among Treatment-Naive Patients in Beijing, China.

Authors:  Fengting Yu; Qun Li; Linghang Wang; Hongxin Zhao; Hao Wu; Siyuan Yang; Yunxia Tang; Jiang Xiao; Fujie Zhang
Journal:  Pharmgenomics Pers Med       Date:  2022-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.